1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy
    Meeting Abstract

    Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated results of a phase 1 study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M
    Meeting Abstract

    Tan, D. S. W.; Yang, J. C. H.; Leighl, N. B.; Riely, G. J.; Sequist, L. V.; Felip, E.; Seto, T.; Wolf, J.; Moody, S. E.; Adams, K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I/randomized phase II study of MLN0128 v.s pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304
    Meeting Abstract

    Tap, W. D.; Mahoney, M. R.; Jaslowski, A. J.; Horvath, L. E.; Schwartz, G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types
    Meeting Abstract

    Teo, M.; Zabor, E. C.; Iyer, G.; Bambury, R.; Boyd, M. E.; Rosenberg, J. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARCO28 - A multicenter phase II study
    Meeting Abstract

    Tawbi, H. A. H.; Burgess, M. A.; Crowley, J.; Van Tine, B. A.; Hu, J.; Schuetze, S.; D'Angelo, S. P.; Attia, S.; Priebat, D. A.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Meeting Abstract

    Sweeney, C.; Xie, W.; Regan, M. M.; Nakabayashi, M.; Buyse, M. E.; Clarke, N. W.; Collette, L.; Dignam, J. J.; Fizazi, K.; Habibian, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A patient safety approach to assessing adverse events in oncology: Results from CHARM (Cancer Harm) study
    Meeting Abstract

    Lipitz Snyderman, A. N.; Classen, D.; Pfister, D. G.; Killen, A.; Epstein, A. S.; Anderson, C. B.; Atoria, C. L.; Fortier, E.; Weingart, S. N.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save